Skip to main content

Table 4 Three-year survival by treatment arm stratified by T1-T2 N + stage

From: Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency

T – N stage

Measurement

Number of cases

3 years survival (%)

P-value*

T1&T2N+

Standard

62

51.8

 
 

Brachytherapy

67

57.9

0.343

Others

Standard

77

67.9

 
 

Brachytherapy

67

50.0

0.106

T1&T2

Standard

70

58.2

 
 

Brachytherapy

70

60.1

0.641

T3&T4

Standard

69

63.2

 
 

Brachytherapy

64

46.3

0.205

  1. *P-value ≤ 0.05 is considered significant.